OXALOTM
OXALOTM
A safe symbiotic bio-therapeutic agent with NLT 2.5 billion cells of probiotics (Oxalobacter formigenes, Lactobacillus Acidophilus, Bifidobacterium Lactis, Bacillus Coagulans). OxaloTM is a special probiotic combination and is effective in the prevention and treatment of renal/kidney stones (Nephrolithiasis).
OXALOTM
A safe symbiotic bio-therapeutic agent with NLT 2.5 billion cells of probiotics (Oxalobacter formigenes, Lactobacillus Acidophilus, Bifidobacterium Lactis, Bacillus Coagulans). OxaloTM is a special probiotic combination and is effective in the prevention and treatment of renal/kidney stones (Nephrolithiasis).
.
Therapeutic Uses:
- Nephrolithiasis - Calicum Oxalate stones,
- Recurrent Urolithiasis
Ingredients:
- Each capsule contains NLT 2.5 Billion spores of:
- Oxalobacter Formigenes,
- Lactobacillus Acidophilus,
- Bacillus Coagulans (formerly known as Lactobacillus Sporogenes), and
- Bifidobacterium Lactis
DISCLAIMER: Sanzyme is entitled to use the trademark and brand name “OXALO” anywhere in the world excluding India. Sanzyme does not intend to market and commercialize OXALO in India
Visited 515 times, 1 visit(s) today
Since 1969, when we entered into a Joint Venture with Sankyo (now Daiichi-Sankyo) to make gonadotropins to export to Japan, we’ve been at the forefront of biological hormones, and today we have the necessary technological foundation to do path breaking work.